Earlier studies using either the TG or TPO promoter found that they were activated by TTF-1 and HNF3β/FoxA2 in thyroid carcinoma cell lines (Sato and Di Lauro, 1996; Ros et al, 1999; Shimura et al, 2001). The gene discussed is FOXA2; the disease is thyroid gland carcinoma.